Skip to content
naulon
Not checkedNot checked for notices yet.

Status of Blood Products Release at a General Hospital in Gyeonggi-Do

Ho-Keun Choi, Kyung-Suk Choi

Korean Journal of Clinical Laboratory Science · 2022

doi:10.15324/kjcls.2022.54.1.73 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Blood products (BPs) can only be obtained through blood donation and hence represent a finite resource.BPs should therefore be used conservatively.However, BPs are being used indiscriminately without evidence.The purpose of this study was to evaluate the reasons for the use of BPs and their appropriateness.The investigation was carried out based on hemoglobin levels.Data were obtained from Nov 1, 2020, to Oct 31, 2021, from a hospital's OCS/EMR systems.The BPs were dispensed in 21,303 cases, and the number of hemoglobin levels >7.0 g/dL or higher among red blood cell drugs used by each treatment department was 1,173 (>7.0 g/dL).The misuse of blood transfusions is increasing social costs, with the adequacy of transfusion becoming increasingly important.Hence, each medical institution should review the transfusion guideline evaluation index, check the status of the release of BPs, and institute educational programs covering transfusion guidelines and continually evaluate their adequacy.

Abstract licence: CC BY-NC

References11

    11 more references, whose wording the paper’s licence keeps private.

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.